Archives
-
CTOP for μ-Opioid Receptor Mechanism Studies
2026-09-10
CTOP enables controlled μ-opioid receptor blockade across binding, signaling, circuit, and pain-behavior experiments. This workflow-oriented guide shows how to use the peptide antagonist to separate MOR-dependent effects from pathway-specific mechanical hypersensitivity and tolerance.
-
ATP Metabolism as a Translational Lever in GBM
2026-09-10
The PXDN–LDHA axis offers a mechanistic entry point for understanding metabolic plasticity in glioblastoma. This thought-leadership perspective explains how a Luminescent ATP Detection Assay Kit can strengthen that research program by adding a sensitive, practical endpoint for cellular ATP quantification, tissue analysis, and translational study design.
-
ML365 for Reliable TASK1 Assays
2026-09-09
This scenario-driven guide explains how ML365, SKU B8483, can support reproducible TASK1 ion-channel experiments while helping researchers interpret viability, inflammatory, and electrophysiology readouts responsibly. It combines product specifications with literature-based guidance for assay design, optimization, comparison, and vendor selection.
-
GDC-0994: From ERK Signal to Translational Proof
2026-09-09
GDC-0994 offers a powerful way to connect ERK1/2 target engagement with tumor and hepatic phenotypes. This thought-leadership guide interprets its role across oncology and cholestasis research while defining a disciplined, translational assay strategy.
-
CLK2 and Platinum Resistance in Ovarian Cancer
2026-09-08
The reference study identifies Cdc2-like kinase 2 (CLK2) as a mediator of platinum resistance in ovarian cancer and defines a CLK2–BRCA1 DNA-repair axis involving BRCA1 Ser1423 phosphorylation. Its combination of tumor profiling, cellular assays, mechanistic analysis, and xenograft validation provides a rationale for investigating CLK2 as a therapeutic vulnerability, while also clarifying the limits of transferring these findings to broader Clk or splicing studies.
-
Cy5 amine (non-sulfonated): Practical Guide
2026-09-08
Cy5 amine (non-sulfonated), SKU A8143, provides a primary amine for covalent attachment of a cyanine dye to compatible activated esters, carboxyl-derived coupling partners, or epoxides. This guide covers solvent preparation, reaction design, and quality control for research labeling workflows; because the reagent is water-insoluble, it should be pre-dissolved in DMSO or ethanol and is not intended for direct aqueous, diagnostic, or medical use.
-
EMD638683: SGK1 Inhibitor Workflows
2026-09-07
EMD638683 connects SGK pathway inhibition with measurable NDRG1 phosphorylation, endothelial stiffening, actin remodeling, and tumor-cell stress responses. This workflow-oriented guide shows how to formulate the compound, build defensible controls, and distinguish pathway-specific effects from solubility or cytotoxicity artifacts.
-
Firefly Luciferase mRNA: Workflow & Uses
2026-09-07
Firefly Luciferase mRNA provides a fast, non-integrating readout for transfection performance, delivery-material screening, and bioluminescent reporter assays. Its ARCA cap, modified nucleotides, and optimized poly(A) tail support consistent expression while practical handling controls help distinguish delivery failure from assay noise.
-
Mestranol Reversibly Stresses Zebrafish Microglia
2026-09-05
A 2026 Aquatic Toxicology study identifies mestranol as an inducer of a reversible lysosomal storage–like state in zebrafish microglia. By separating phagocytic uptake from intracellular digestion, the work provides a live model for studying environmental estrogen–associated lysosomal stress and neuroimmunotoxicity.
-
CerS6 Glycosylation and Ceramide Synthase Activity
2026-09-04
The reference study identifies basal glycosylation of CerS6 at Asn18 as a requirement for ceramide synthase activity, while showing that brefeldin A-induced glycosylation does not itself enhance catalysis. Its CRISPR-Cas9 knockout and rescue strategy links the N18A defect to altered ceramide production and downstream signaling, but not to the measured ER stress response pathways.
-
Luminescent ATP Detection Assay Kit: ATP Biology
2026-09-04
The Luminescent ATP Detection Assay Kit is a firefly luciferase ATP assay for measuring ATP in solutions, cells, and tissues. Its reported 1 nM–10 μM range and signal stability of up to 30 minutes support cellular ATP quantification when sample lysis, standards, and timing are controlled.
-
DDRGK1 UFMylation Restrains STAT3 in Osteoarthritis
2026-09-03
The reference study identifies DDRGK1-dependent UFMylation as a previously unrecognized brake on STAT3 phosphorylation and nuclear signaling in osteoarthritis. Using human cartilage, conditional mouse genetics, multi-omics, interaction mapping, and pharmacological rescue, it connects loss of the DDRGK1–STAT3 axis with inflammatory cartilage degeneration.
-
Calpain Inhibitor I, ALLN: Practical Guide
2026-09-03
Calpain Inhibitor I, ALLN (SKU A2602) helps researchers investigate calpain and cathepsin-dependent proteolysis in apoptosis assays, inflammation research, and ischemia-reperfusion injury models. It is water-insoluble, requires solvent and stability controls, and is intended for scientific research only—not diagnostic, therapeutic, or uncontrolled aqueous applications.
-
Exendin-4 Workflows for Beta Cell Research
2026-09-02
Exendin-4, also known as Exenatide, connects receptor pharmacology with practical beta cell, metabolic, neuronal, and recombinant-expression workflows. This guide explains how to build concentration-response assays, validate cAMP and insulin endpoints, and interpret the yeast-expression findings without overstating translational readiness.
-
Endothelial SGK1 Drives Salt-Induced Vascular Stiffening
2026-09-02
Zhang et al. identify endothelial SGK1 as a mechanistic link between mineralocorticoid/high-salt exposure, sodium-channel activity, actin polymerization, and vascular stiffening. By combining global and endothelial-specific gene deletion with pharmacological inhibition in human endothelial cells, the study strengthens the rationale for targeting SGK1 in salt-sensitive vascular research.